Mark William Lowdell serves as Executive at Inmune Bio, Inc., where they oversee executive responsibilities. Since joining the company, Mark William Lowdell has executed 9 insider transactions totaling $812.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 19, 2024 involved receiving (via award) 14,423 shares valued at $120.0K.
Mark William Lowdell currently holds 1,510,806 shares of Inmune Bio, Inc. (INMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark William Lowdell has been a net seller of INMB stock. They have purchased $138.2K and sold $673.9K worth of shares.
Mark William Lowdell's most recent insider trade was on Apr 19, 2024, when they sold 14,423 shares at $8.32 per share.
Get notified when new Form 4 filings are submitted
| $8.32 |
| Discretionary |
| Mar 22, 2022 | INMB | $198.9K | Award | 23,590 | $8.43 | Discretionary |
| Nov 3, 2021 | INMB | $14.0K | Sale | 701 | $20.00 | Discretionary |
| Oct 27, 2021 | INMB | $47.1K | Sale | 2,357 | $20.00 | Discretionary |
| Oct 22, 2021 | INMB | $8.0K | Sale | 400 | $20.00 | Discretionary |
| Jul 8, 2021 | INMB | $487.6K | Sale | 24,150 | $20.19 | Discretionary |
| Jul 7, 2021 | INMB | $117.1K | Sale | 5,850 | $20.02 | Discretionary |
| Sep 11, 2019 | INMB | $18.2K | Purchase | 2,918 | $6.23 | Discretionary |